VEGFA and neoplasm: As hoped, integrating anti-VEGF bevacizumab with immunotherapy helps stabilize the tumor vasculature, support the penetration of immune cells and drugs into the tumors and hence boost immunotherapy effectiveness in pre-clinical models (94, 124).